임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

15건 표시

1/2상모집 중단 (진행 중)· Untreated Myelodysplastic Syndrome
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
협력: 애브비, BMS
상세 →NCT05782127
1/2상모집 중단 (진행 중)· MDS
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
협력: 애브비
상세 →NCT05226455
1/2상모집 중단 (진행 중)· Refractory Acute Lymphoblastic Leukemia
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
협력: 애브비
상세 →NCT05192889
1/2상모집 중단 (진행 중)· B-Cell Non-Hodgkin Lymphoma
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
협력: 애브비
상세 →NCT05201248
1/2상모집 중단 (진행 중)· Diffuse Large B Cell Lymphoma
Copanlisib Plus Venetoclax in R/R DLBCL
협력: 애브비
상세 →NCT04572763
1/2상모집 중단 (진행 중)· Relapsed/Refractory Chronic Lymphocytic Leukemia
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
협력: 애브비, 일라이 릴리
상세 →NCT04623541
1/2상모집 중단 (진행 중)· Open-angle Glaucoma
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
리드: 애브비
상세 →NCT04499248
1/2상모집 중단 (진행 중)· Diffuse Large B-Cell Lymphoma
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
협력: 애브비
상세 →NCT04663347
1/2상모집 중단 (진행 중)· Diffuse Large B Cell Lymphoma
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
협력: 애브비
상세 →NCT04542824
1/2상모집 중단 (진행 중)· Acute Myeloid Leukemia
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
리드: 애브비
상세 →NCT04086264
1/2상모집 중단 (진행 중)· Multiple Myeloma
A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma
리드: 애브비
상세 →NCT03933735
1/2상모집 중단 (진행 중)· DLBCL
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
협력: 애브비
상세 →NCT03625037
1/2상모집 중단 (진행 중)· Blastic Plasmacytoid Dendritic Cell Neoplasm
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
리드: 애브비
상세 →NCT03386513
1/2상모집 중단 (진행 중)· Breast Neoplasms
Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer
협력: 애브비
상세 →NCT03379428
1/2상모집 중단 (진행 중)· Leukemia
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
협력: 애브비
상세 →NCT03319901

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.